<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-8VABS1X3/4b5c2131-5947-441d-a9d5-a43799325393/HTML"><dcterms:extent>28 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-8VABS1X3/647372be-325a-4cc5-86e7-a2122664c03a/PDF"><dcterms:extent>499 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-8VABS1X3/6dc1965e-61ac-4e15-a5e9-08215d7bf08a/TEXT"><dcterms:extent>26 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1929-2026"><edm:begin xml:lang="en">1929</edm:begin><edm:end xml:lang="en">2026</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:DOC-8VABS1X3"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/urn:nbn:si:spr-a30mfzkp" /><dcterms:issued>2010</dcterms:issued><dc:creator>Globočnik Petrovič, Mojca</dc:creator><dc:creator>Hawlina, Gregor</dc:creator><dc:creator>Štunf, Špela</dc:creator><dc:format xml:lang="sl">7 strani</dc:format><dc:format xml:lang="sl">letnik:79</dc:format><dc:format xml:lang="sl">str. I-68-I-74</dc:format><dc:format xml:lang="sl">številka:suplement</dc:format><dc:identifier>ISSN:1318-0347</dc:identifier><dc:identifier>COBISSID:27814361</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-8VABS1X3</dc:identifier><dc:language>en</dc:language><dc:publisher xml:lang="sl">Slovensko zdravniško društvo</dc:publisher><dcterms:isPartOf xml:lang="sl">Zdravniški vestnik</dcterms:isPartOf><dc:subject xml:lang="sl">degeneracija</dc:subject><dc:subject xml:lang="sl">Indocianin zeleno</dc:subject><dc:subject xml:lang="en">Indocyanine Green</dc:subject><dc:subject xml:lang="sl">kirurško zdravljenje</dc:subject><dc:subject xml:lang="en">Macular Degeneration</dc:subject><dc:subject xml:lang="sl">makula</dc:subject><dc:subject xml:lang="sl">Makula, degeneracija</dc:subject><dc:subject xml:lang="sl">oftalmologija</dc:subject><dc:subject xml:lang="sl">ostrina vida</dc:subject><dc:subject xml:lang="en">Retrospective Studies</dc:subject><dc:subject xml:lang="sl">Retrospektivne študije</dc:subject><dc:subject xml:lang="sl">Vid, ostrina</dc:subject><dc:subject xml:lang="en">Visual Acuity</dc:subject><dc:subject xml:lang="en">Vitrectomy</dc:subject><dc:subject xml:lang="sl">Vitrektomija</dc:subject><dcterms:temporal rdf:resource="1929-2026" /><dc:title xml:lang="sl">Visual outcome of idiopathic epimacular membrane surgery| Uspešnost kirurškega zdravljenja idiopatske epimakularne membrane|</dc:title><dc:description xml:lang="sl">Background: Vitrectomy and removal of idiopathic epimacular membrane (IEM) is one of the most effective procedure in vitreoretinal surgery. The aim of our study was to evaluate the visual outcome after vitrectomy in eyes with IEM. Because of potential dose-dependent toxicity of indocyanin green (ICG) the authors compared the visual outcome after different concentration of ICG assisted vitrectomy. Methods: A retrospective analysis of visual outcome in 104 consecutively operated patients (65 female, 39 male) with IEM. The comparison in pre-operative and post-operative visual acuity, as visual gain was undertaken. Furthermore, the comparison in visual outcome between 1.25 mg/ml ICG (patients) and 0.5 mg/ml ICG (patients) assisted vitrectomy was performed. Results: Main pre-operative best corrected visual acuity (BCVA) was0.3 0.2; 0.01 - 0.8 (mean SD; min.-max.). Main post-operative BCVA 3 and 8 months after the procedure was 0.5 0.3; 0.1 - 1.00 and 0.6 0.3; 0.01- 1.00 (mean SD; min.-max.), respectively. After 8 months the mean visual gain was 0.29 0.27; -0.40 - 0.9 (mean SD; min.-max.). In comparing 1.25 mg/ ml ICG and 0.5 mg/ml ICG assisted vitrectomy there was no significantdifference in pre-operative visual acuity (p = 0.65), post-operative visual acuity after 3, 8 months (p = 0.2, p = 0.83) and visual gain after 8 months (p = 0.7). Conclusions: Vitrectomy with peeling of epiretinal membrane and ILM leads to significant improvement in visual acuity.The potential dosedependent toxicity and damage to the retina should always be kept in mind whenever using the ICG assisted vitrectomy, although wedid not found any difference in visual gain comparing the 1.25 mg/ml ICG andthe 0.5 mg/ml ICG assisted vitrectomy</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:DOC-8VABS1X3"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:DOC-8VABS1X3" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:DOC-8VABS1X3/647372be-325a-4cc5-86e7-a2122664c03a/PDF" /><edm:rights rdf:resource="http://creativecommons.org/licenses/by-nc/4.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Slovensko zdravniško društvo</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:DOC-8VABS1X3/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:DOC-8VABS1X3" /></ore:Aggregation></rdf:RDF>